On August 3rd, the Partnership released an article regarding increased use of the two substances, gabapentin and pregabalin, which are prescribed to treat seizures and nerve pain. This article discusses information about recent abuse trends, and demographics of users. Coincidentally, many users abusing these drugs are also abusing opioids.